NCT00372957View on ClinicalTrials.gov

Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 22, 2006

Primary Completion Date

June 28, 2006

Study Completion Date

June 28, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

GW823093 15mg

White opaque capsule containing 15mg of GW823093 as free base

DRUG

GW823093 placebo capsule

Matching placebo of GW823093 capsule or 15mg capsule

DRUG

GW823093 30mg

White opaque capsule containing 15mg of GW823093 as free base

Trial Locations (1)

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00372957 - Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter